GM Advisory Group LLC Decreases Position in Axon Enterprise, Inc. (NASDAQ:AXON)

GM Advisory Group LLC cut its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 5.7% in the 4th quarter, Holdings Channel reports. The institutional investor owned 2,182 shares of the biotechnology company’s stock after selling 131 shares during the quarter. GM Advisory Group LLC’s holdings in Axon Enterprise were worth $1,297,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of the company. OneDigital Investment Advisors LLC raised its holdings in shares of Axon Enterprise by 35.8% during the third quarter. OneDigital Investment Advisors LLC now owns 2,053 shares of the biotechnology company’s stock valued at $820,000 after purchasing an additional 541 shares during the last quarter. CIBC Asset Management Inc raised its holdings in shares of Axon Enterprise by 9.2% during the third quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock valued at $4,227,000 after purchasing an additional 895 shares during the last quarter. Natixis Advisors LLC raised its holdings in shares of Axon Enterprise by 5.4% during the third quarter. Natixis Advisors LLC now owns 30,392 shares of the biotechnology company’s stock valued at $12,145,000 after purchasing an additional 1,552 shares during the last quarter. Fifth Third Wealth Advisors LLC raised its holdings in shares of Axon Enterprise by 35.4% during the third quarter. Fifth Third Wealth Advisors LLC now owns 1,082 shares of the biotechnology company’s stock valued at $432,000 after purchasing an additional 283 shares during the last quarter. Finally, Banque Cantonale Vaudoise raised its holdings in shares of Axon Enterprise by 2.3% during the third quarter. Banque Cantonale Vaudoise now owns 7,381 shares of the biotechnology company’s stock valued at $2,950,000 after purchasing an additional 165 shares during the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

Axon Enterprise Stock Performance

AXON opened at $539.99 on Wednesday. The firm has a market cap of $41.38 billion, a P/E ratio of 139.53, a PEG ratio of 5.17 and a beta of 1.12. Axon Enterprise, Inc. has a 1-year low of $273.52 and a 1-year high of $715.99. The company has a 50 day simple moving average of $592.66 and a two-hundred day simple moving average of $539.27. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63.

Insiders Place Their Bets

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 1,035 shares of the company’s stock in a transaction that occurred on Monday, December 23rd. The shares were sold at an average price of $624.47, for a total value of $646,326.45. Following the completion of the transaction, the insider now directly owns 124,243 shares in the company, valued at $77,586,026.21. This represents a 0.83 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Jeri Williams sold 307 shares of the company’s stock in a transaction on Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the transaction, the director now owns 1,627 shares of the company’s stock, valued at approximately $899,275.44. This represents a 15.87 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 1,792 shares of company stock worth $1,087,843 over the last three months. 5.70% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several research analysts have recently weighed in on the stock. Needham & Company LLC reissued a “buy” rating and set a $600.00 price objective on shares of Axon Enterprise in a report on Wednesday, February 26th. The Goldman Sachs Group boosted their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a report on Monday, January 27th. TD Cowen began coverage on shares of Axon Enterprise in a report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price objective for the company. Northcoast Research lowered shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. Finally, Robert W. Baird boosted their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $604.67.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.